Lecturer

Dr Carole Abigail Harris

MBBS (Hons) BPharm FRACP MMed

medicine-health
St. George Clin Sch- Operating

Dr Carole Harris is a clinical academic at St George and Sutherland Clinical School, UNSW and a medical oncologist at St George and Sutherland Hospitals.

Publications

  • Book Chapters | 2008
    Dr Carole Abigail Harris
    Goldstein D; Harris C; Harris C, 2008, 'Advances in treatment options for patients with pancreatic cancer', in Touch Briefings Asia Pacific, edn. Original
  • Journal articles | 2019
    Dr Carole Abigail Harris
    Schmidt A; Azad A; Goh J; Harris C; Joshua AM; Weickhardt A; Krieger L, 2019, 'Treatment selection for first-line metastatic renal cell carcinoma in Australia: Impact of new therapy options', Asia-Pacific Journal of Clinical Oncology, vol. 15, pp. 3 - 10, http://dx.doi.org/10.1111/ajco.13289
    Journal articles | 2017
    Dr Carole Abigail Harris
    Harris CA; Daniels BJ; Ward RL; Pearson SA, 2017, 'Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2 positive early breast cancer patients (2008-2012)', Public Health Research and Practice, vol. 27, http://dx.doi.org/10.17061/phrp2751744
    Journal articles | 2011
    Dr Carole Abigail Harris
    Adelstein BA; Dobbins TA; Harris CA; Marschner IC; Ward RL, 2011, 'A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer', European Journal of Cancer, vol. 47, pp. 1343 - 1354, http://dx.doi.org/10.1016/j.ejca.2011.03.031
    Journal articles | 2011
    Dr Carole Abigail Harris
    Harris CA; Ward RL; Dobbins TA; Drew A; Pearson S, 2011, 'The efficacy of HER2-targeted agents in metastatic breast cancer: A meta-analysis', Annals of Oncology, vol. 22, pp. 1308 - 1317, http://dx.doi.org/10.1093/annonc/mdq593
    Journal articles | 2010
    Dr Carole Abigail Harris
    Goldstein D; Harris C; Harris C, 2010, 'Tamoxifen use in retroperitoneal fibrosis, case report and review of the literature', Internal Medicine Journal, vol. 40, pp. e5 - e7
  • Conference Abstracts | 2020
    Dr Carole Abigail Harris
    Gedye C; Pook DW; Krieger LEM; Harris CA; Goh JC; Kichenadasse G; Gurney H; Underhill C; Parnis F; Joshua AM; Ferguson T; Roncolato F; Harrison ML; Morris MF; Begbie S; Hovey EJ; George M; Prithviraj P; Liow ECH; Davis ID, 2020, 'UNISON: Nivolumab then ipilimumab plus nivolumab in advanced nonclear cell renal cell carcinoma (ANZUP 1602)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Francisco, CA, Vol. 38, presented at Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA, 13 February 2020 - 15 February 2020, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000529525900071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Papers | 2013
    Dr Carole Abigail Harris
    Harris CA; Ward RL; Daniels B; Pearson S, 2013, 'Do pharmaceutical claims accurately reflect oncology prescribing practice? Evidence from an Australian HER2+early breast cancer cohort ( HER2EBC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Diego, CA, presented at ASCO's Quality Care Symposium, San Diego, CA, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.100
    Conference Papers | 2013
    Dr Carole Abigail Harris
    Harris CA; Pearson S; Daniels B; Srasuebkul P; Ward RL, 2013, 'HER2-positive early breast cancer (HER2EBC): An Australian pattern of care study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, San Diego, CA, presented at ASCO's Quality Care Symposium, San Diego, CA, 01 November 2013 - 02 November 2013, http://dx.doi.org/10.1200/jco.2013.31.31_suppl.101
    Conference Papers | 2010
    Dr Carole Abigail Harris
    Pearson S; Srasuebkul P; Harris C; Ward RL; Dobbins TA; Harris C, 2010, 'Trastuzumab treatment outcomes according to concomitant chemotheray regimen: Overall survival of HER2+ metastatic breast cancer patients', in Storm BL; Hasford J; Hennessy S; Park BJ (eds.), Pharmacoepidemiology and Drug Safety, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S187 - S187, presented at Pharmacoepidemiology & Therapeutic Risk Management, Brighton, UK, 19 August 2010 - 22 August 2010, http://dx.doi.org/10.1002/pds

Awards

Grants

2019 ANZUP Below the Belt Research Award. What, where, when and how long? Using PBS data to understand patterns of care and survival in Australian patients treated for metastatic clear cell kidney cancer. Carole Harris, Richard De Abreu Lourenco, Craig Gedye

2018 UNSW Medicine Cancer CAG seed grant. Exercise rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy: Impact and mechanisms David Goldstein, Susanna Park, J. Matt McCrary, Jasmine Menant, Carole Harris, David Simar

2009 NHMRC Targeted cancer therapies: Their use, effectiveness and cost effectiveness in real world clinical practice

Media